Anna Greka is an Associate Professor of Medicine at Harvard Medical School, a physician at Brigham and Women’s Hospital, and an Institute Member of the Broad Institute of MIT and Harvard. Seeking to lay the foundation for molecularly targeted therapies, Anna leads a program aimed at dissecting fundamental mechanisms of cellular homeostasis and their disruption in genetically-defined kidney, metabolic and degenerative diseases, with a special focus on membrane proteins.
Anna has been the recipient of several honors, including the Donald W. Seldin Young Investigator Award by the American Society of Nephrology and the American Heart Association, the Seldin-Smith Award for Pioneering Research from the American Society of Clinical Investigation (ASCI), and a Presidential Early Career Award for Scientists and Engineers (PECASE). She was also elected to the ASCI Council by her peers, and is a member of the National Academy of Medicine’s Emerging Leaders forum. Anna serves on the Harvard-MIT M.D.-Ph.D. Program Leadership Council and on the Board of Trustees of Anatolia College in Thessaloniki, Greece.
Anna holds an A.B. in biology from Harvard College, an M.D. from the Harvard-MIT program in Health Sciences and Technology (HST) and a Ph.D. in neurobiology from HMS.